Rapid Medical Diagnostic Kits Market is Projected to Expand at a CAGR of More than 4% by 2031

April 14, 2021

Fact.MR’s detailed study on the rapid medical diagnostic kits market forecasts the landscape to accrue significant gains through 2031.

Rising prevalence of infectious diseases has been surging demand for rapid medical diagnostic kits, globally. Need for detecting new pathogens that are causing infections is boosting market growth. There has also been a noticeable decrease in the immune systems of people due to sedentary and unhealthy lifestyles, which makes them vulnerable to infections, thus, supplementing demand for rapid medical diagnostic kits.

Increasing geriatric population worldwide is also anticipated to aid market growth. Emergence of cheap rapid medical diagnostic kits, especially with the onset of the COVID-19 pandemic, is another factor catalyzing sales across regions. As per Fact.MR analysis, the global rapid medical diagnostic kits market is projected to expand at a steady CAGR of around 4% through 2031.

For more insights into the Market, Request a Sample of this Report https://www.factmr.com/connectus/sample?flag=S&rep_id=5584

Key Takeaways from Study

Blood glucose testing kits will remain the most-used over the long term, experiencing over two-fold growth through 2031.

North America to remain as a highly lucrative market; the region is witnessing high adopting these diagnostic kits to detect various infectious diseases caused by bacteria and viruses.

Europe to experience steady annual growth through 2031, driven by heightened investments to improve the condition of healthcare facilities.

Hospitals & clinics will continue to remain as the largest end-user segment demanding the highest volumes of rapid medical diagnostic kits.

“The outbreak of COVID-19 has created significant opportunity for manufacturers to develop rapid medical diagnostic kits to contain the spread of the virus,” says a Fact.MR analyst.

Prominent Market Drivers

Increasing prevalence of multidrug-resistant bacterial infections is set to propel demand for rapid medical testing.

Expanding population, genetic variation in hosts and pathogens, and environmental change are some other aspects contributing to increased demand for rapid medical testing, thereby boosting industry expansion.

Growing prevalence of chronic diseases is leading to an increase in the need for rapid disease diagnosis.

Share Your Requirements & Get Customized Reports https://www.factmr.com/connectus/sample?flag=RC&rep_id=5584

Market Competition

Key manufacturers profiled in Fact.MR’s report includes Danaher Corporation, ACON Laboratories, Inc., Meridian Bioscience, Inc., Becton, Dickinson, and Company, Abbott Laboratories, Artron Laboratories Inc., Alfa Scientific Designs, Inc., BTNX, Inc., bioMérieux SA, Cardinal Health, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, McKesson Medical-Surgical, Inc., Trinity Biotech, and Zoetis, among others. Primary expansion strategies include acquisition of key distributors, collaborations, mergers, and product portfolio diversification.

More Valuable Insights

Fact.MR, in its new offering, brings to fore an unbiased analysis of the global rapid medical diagnostic kits market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges compelling insights on the market based on test (blood glucose testing, infectious disease testing, pregnancy and fertility testing, cholesterol monitoring, and other tests) and application (hospitals & clinics, homecare settings, and veterinary), across seven major regions of the world.

Explore Fact.MR’s Coverage on the Healthcare Domain

Home Diagnostics Market: A recent study by Fact.MR on the Home Diagnostics market offers a 10-year forecast analysis for the period 2020 to 2030. The study analyzes key trends that are currently influencing the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Medical Suction Devices Market: Fact.MR’s extensive coverage on the Medical Suction Devices Market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Dermatology Diagnostic Devices Market: The global Dermatology Diagnostic Devices Market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in forthcoming years.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed.

Research Insight: https://www.factmr.com/report/rapid-medical-diagnostic-kits-market

Content Source: https://www.factmr.com/media-release/1851/global-rapid-medical-diagnostic-kits-market

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel:+1 (628) 251-1583
E: sales@factmr.com
Follow Us:LinkedIn | Twitter

SourceFact.MR

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version